Abstract:BACKGROUND & OBJECTIVEInterferon-gamma-inducible protein 10 (IP-10), a member of alpha-chemoattractant family, is an inhibitor of tumor angiogenesis. Chemotherapy combined with antiangiogenic therapy has synergistic effects. This study was designed to explore antitumor effect of IP-10 combined with gemcitabine in tumor-bearing mice.METHODSpBLAST-IP-10 was transferred into E.coli to prepare and purify plasmid IP-10. Hepatocarcinoma H22 model was established in BALB/c miceu Lewis lung cancer LL/2 model was established in C57BL/6 mice. The mice were divided into 4 groups, and treated with IP-10, gemcitabine, IP-10 plus gemcitabine, and normal saline (control), respectively. Protein level of IP-10 in serum was detected by ELISA. Survival rate of mice, tumor volume, and side effects of treatment were observed. Microvessel density (MVD) of tumor tissue was detected by immunohistochemistry. Apoptosis of tumor cells was detected by TUNEL method.RESULTSAfter treatment of IP-10, IP-10 protein reached the peak level of (16.8+/-3.6) ng/ml at the 14th day, and remained a high level of (14.0+/-2.1) ng/ml at the 35th day. Compared with the controls, tumor volume of mice in the combination therapy group had significant regression, or disappeared. Nine weeks after inoculation of tumor cells, survival rate of mice was significantly higher in combination group than in IP-10, gemcitabine, and control groups (90% vs. 55%, 0%, and 0%, P < 0.005). No obvious side effects were observed. MVD of tumor tissues was significantly lower in combination group than in IP-10, gemcitabine, and control groups (15.8+/-2.4 vs. 45.6+/-2.0, 50.2+/-3.5, and 51.3+/-3.0, P < 0.01). At the 35th day after inoculation of tumor cells, apoptosis index was significantly higher in combination group than in IP-10, gemcitabine, and control groups (85.5+/-10.2 vs. 21.4+/-5.5, 8.4+/-2.0, 4.2+/-0.7, P < 0.01).CONCLUSIONTherapy of IP-10 combined with gemcitabine has significantly synergistic antitumor effect compared with IP-10 or gemcitabine alone.

Antitumor Effects of Peptide HM-3 and Gemcitabine against Experimental Lewis Lung Cancer

Antitumor effects of peptide HM-3 against non-small cell lung cancer xenografts in nude mice

Curative Effect of Gemcitabine Combined with Platinum Drugs on Treatment of Advanced Squamous Carcinoma and Adenocarcinoma of Lung

Combination Therapy Of Vegf-Trap And Gemcitabine Results In Improved Anti-Tumor Efficacy In A Mouse Lung Cancer Model

Experimental Study on Improving Radiosensitivity for Lewis Lung Cancer with Gemcitabine

Antitumor Effects of Integrin Inhibitor HM-3 and Cyclophosphamide in Mouse Melanoma

Inhibition of Expression of Vascular Endothelial Growth Factor and Its Receptors in Pulmonary Adenocarcinoma Cell by TNP-470 in Combination with Gemcitabine

Experimental Research on TMP Combination with DDP in Treating Lewis Lung Carcinoma

Clinical trial of advanced non-small cell lung cancer by combination of gemci-tabine and cisplatin

[Corrigendum] in Vitro and in Vivo Activities of an Antitumor Peptide HM-3: A Special Dose-Efficacy Relationship on an HCT‑116 Xenograft Model in Nude Mice.

The Combination Effect of Gemcitabine with Mitomycin on Human Lung Cancer A549 Cell Line in Vitro

[Anti-Angiogenic Effects of Low-Dose Gemcitabine Combined with Ginsenoside Rg3 on Mouse Lewis Lung Carcinoma].

Efficacy of 3LL/GM-CSF Tumor Vaccine Combined with Pacilitaxel Chemotherapy in Treatment of Mice Bearing Transplanted Lewis Lung Carcinoma

Inhibitory effect of harmine derivative B-9-3 combined with five traditional anti-tumor drugs on cancer cells in vitro

[Study on the Anti-Lewis Lung Carcinoma Effect of Metformin Combined with MCT1 Inhibitor CHC].

The Synergetic Effect of Ginsenoside and Gemcitabine on Human Lung Cancer Cells Derived from Pleural Effusion

HM-3-HSA exhibits potent anti-angiogenesis and antitumor activity in hepatocellular carcinoma

Enhanced Therapeutic Effect of an Antiangiogenesis Peptide on Lung Cancer in Vivo Combined with Salmonella VNP20009 Carrying a Sox2 Shrna Construct

Comparison of the Clinical Effect of Cisplatin combined with Docetaxel, Pemetrexed and Gemcitabine on Advanced Lung Adenocarcinoma

[Antitumor Effects of Interferon-Gamma-inducible Protein 10 Combined with Gemcitabine].

Clinical Effects of Gemcitabine Combined with Pemetrexed on Patients with Advanced Non-Small Cell Lung Cancer